Who owns MARINUS PHARMACEUTICALS INC?
- Ticker: MRNS
- CUSIP Number: 56854q200
Tip: Access positions for across all investors
Analyze quarterly positions in Marinus Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Marinus Pharmaceuticals stock
Who bought or sold MARINUS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Eventide Asset Management | 4.5M | $49M | 0% | Dec 2023 |
|
| Franklin Resources | 3.8M | $42M | 1% | Dec 2023 |
|
| Cormorant Asset Management | 3.3M | $35M | 24% | Dec 2023 |
|
| venBio Select Advisor | 3.2M | $34M | 0% | Dec 2023 |
|
| Jennison Associates | 3.0M | $32M | 0% | Dec 2023 |
|
| Vanguard Group | 2.7M | $29M | 4% | Dec 2023 |
|
| Lion Point Capital | 2.1M | $23M | -1% | Dec 2023 |
|
| Bleichroeder | 1.9M | $20M | 0% | Dec 2023 |
|
| GMT Capital Corp | 1.7M | $19M | 0% | Dec 2023 |
|
| Ikarian Capital | 746k | $8.1M | 0% | Dec 2023 |
|
| Citadel Advisors | 718k | $7.8M | 10% | Dec 2023 |
|
| Opaleye Management | 564k | $6.1M | -4% | Dec 2023 |
|
| Standard Life Aberdeen | 553k | $6.0M | 100% | Dec 2023 |
|
| Point72 Asset Management | 493k | $5.4M | -54% | Dec 2023 |
|
| Superstring Capital Management | 462k | $5.0M | 100% | Dec 2023 |
|
| Caption Management | 321k | $3.5M | 1879% | Dec 2023 |
|
| Assenagon Asset Management | 271k | $2.5M | 0% | Mar 2024 |
|
| Walleye Trading Advisors | 265k | $2.9M | -26% | Dec 2023 |
|
| Wellington Management Company | 241k | $2.6M | 55% | Dec 2023 |
|
| Propel Bio Management | 180k | $2.0M | 100% | Dec 2023 |
|
| Bank of New York Mellon | 160k | $1.4M | -6% | Mar 2024 |
|
| Simplify Asset Management | 150k | $1.6M | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 149k | $1.6M | 8% | Dec 2023 |
|
| Jane Street | 98k | $1.1M | -29% | Dec 2023 |
|
| Simplex Trading | 92k | $834k | 100% | Mar 2024 |
|
| Victory Capital Management | 83k | $905k | -12% | Dec 2023 |
|
| UBS Group | 83k | $903k | 48% | Dec 2023 |
|
| Barclays | 76k | $830k | 747% | Dec 2023 |
|
| Rhumbline Advisers | 76k | $824k | 7% | Dec 2023 |
|
| Goldman Sachs Group | 73k | $789k | -38% | Dec 2023 |
|
| Trexquant Investment | 51k | $553k | 100% | Dec 2023 |
|
| Alpha DNA Investment Management | 50k | $540k | -36% | Dec 2023 |
|
| Bank of America Corporation | 46k | $497k | -13% | Dec 2023 |
|
| Jpmorgan Chase & Co | 44k | $479k | 0% | Dec 2023 |
|
| Mach-1 Financial Group | 44k | $476k | -36% | Dec 2023 |
|
| AE Wealth Management | 43k | $434k | -37% | Dec 2023 |
|
| Two Sigma Investments | 41k | $448k | -24% | Dec 2023 |
|
| Alliancebernstein | 39k | $427k | 13% | Dec 2023 |
|
| Torno Capital | 38k | $413k | 100% | Dec 2023 |
|
| Grimes & Company | 34k | $303k | -2% | Mar 2024 |
|
| Dimensional Fund Advisors | 29k | $317k | -9% | Dec 2023 |
|
| T. Rowe Price Associates | 28k | $308k | 3% | Dec 2023 |
|
| MetLife Investment Advisors | 26k | $287k | 0% | Dec 2023 |
|
| Millennium Management | 26k | $279k | 100% | Dec 2023 |
|
| Mirae Asset Global Investments | 25k | $277k | 1% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 25k | $274k | -3% | Dec 2023 |
|
| American International | 25k | $274k | 0% | Dec 2023 |
|
| Wolverine Trading | 24k | $257k | -71% | Dec 2023 |
|
| AQR Capital Management | 23k | $250k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 17k | $186k | -15% | Dec 2023 |
|
| Royal Bank of Canada | 15k | $166k | 124% | Dec 2023 |
|
| Walleye Trading | 15k | $166k | -57% | Dec 2023 |
|
| Florida State Board of Administration | 15k | $157k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 14k | $152k | 31% | Dec 2023 |
|
| Denali Advisors | 14k | $123k | 0% | Mar 2024 |
|
| SG Americas Securities | 12k | $134k | 100% | Dec 2023 |
|
| Corton Capital | 11k | $120k | 100% | Dec 2023 |
|
| Values First Advisors | 10k | $94k | -27% | Mar 2024 |
|
| Citigroup | 8.2k | $89k | 1150% | Dec 2023 |
|
| China Universal Asset Management | 6.3k | $69k | 384% | Dec 2023 |
|
| Advisor Group Holdings | 5.8k | $63k | -4% | Dec 2023 |
|
| Legal & General Group | 5.6k | $61k | -3% | Dec 2023 |
|
| Summit Investment Advisors | 5.2k | $57k | 28% | Dec 2023 |
|
| Coppell Advisory Solutions | 5.0k | $54k | 100% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 2.7k | $30k | 0% | Dec 2023 |
|
| Zurcher Kantonalbank | 1.8k | $16k | -32% | Mar 2024 |
|
| Amalgamated Bank | 1.7k | $15k | -76% | Mar 2024 |
|
| Absolute Investment Management | 1.0k | $11k | -20% | Dec 2023 |
|
| Signature | 342.00 | $3.7k | 83% | Dec 2023 |
|
| Hanson McClain Advisors | 317.00 | $2.9k | 20% | Mar 2024 |
|
| Lindbrook Capital | 242.00 | $2.2k | 0% | Mar 2024 |
|
| Fifth Third Bancorp | 115.00 | $1.0k | 0% | Mar 2024 |
|
| Advisory Services Network | 76.00 | $825.998400 | 100% | Dec 2023 |
|
| Daiwa Securities Group | 58.00 | $1.0k | 0% | Dec 2023 |
|
| GAMMA Investing | 56.00 | $505.999200 | 40% | Mar 2024 |
|
| Harbor Investment Advisory | 37.00 | $333.999000 | 0% | Mar 2024 |
|
| Quadrant Capital | 22.00 | $240.000200 | -92% | Dec 2023 |
|
| Farther Finance Advisors | 14.00 | $151.999400 | 100% | Dec 2023 |
|
| NISA Investment Advisors | 12.00 | $129.999600 | 100% | Dec 2023 |
|
| Pnc Financial Services | 7.00 | $75.999700 | 100% | Dec 2023 |
|
Who sold out of Marinus Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Sep 2023 | 253k | $2.0M |
| D. E. Shaw & Co | Sep 2023 | 61k | $494k |
| Worth Venture Partners | Sep 2023 | 42k | $341k |
| Moore Capital Management | Sep 2023 | 31k | $251k |
| Two Sigma Advisers | Sep 2023 | 20k | $159k |
| Sherbrooke Park Advisers | Sep 2023 | 18k | $141k |
| Balyasny Asset Management | Sep 2023 | 16k | $128k |
| Impact Partnership Wealth | Sep 2023 | 749.00 | $6.0k |
| Parallel Advisors | Sep 2023 | 60.00 | $483.000000 |
| Federated Investors | Sep 2023 | 50.00 | $403.000000 |
| SOA Wealth Advisors | Dec 2023 | 40.00 | $435.000000 |
| Russell Investments | Sep 2023 | 38.00 | $305.998800 |